Jaap Rip

Jaap Rip Email and Phone Number

CSO at 20Med Therapeutics @ 20Med Therapeutics
Jaap Rip's Location
Leiden, South Holland, Netherlands, Netherlands
Jaap Rip's Contact Details

Jaap Rip work email

Jaap Rip personal email

n/a
About Jaap Rip

Jaap Rip is a CSO at 20Med Therapeutics at 20Med Therapeutics. They possess expertise in lifesciences, cell biology, biotechnology, biochemistry, drug discovery and 20 more skills. Colleagues describe them as "I have collaborated with Jaap for four years at to-BBB technologies. Jaap has a very good scientific background and insight, and he has managed several projects at to-BBB with great success. I know Jaap as a good manager and a key person within any (scientific) team that has a very natural way of challenging data and ideas, thereby maintaining the necessary positive critical attitude that is required for research and product development. Jaap is very reliable and a great colleague to collaborate with."

Jaap Rip's Current Company Details
20Med Therapeutics

20Med Therapeutics

View
CSO at 20Med Therapeutics
Jaap Rip Work Experience Details
  • 20Med Therapeutics
    Cso
    20Med Therapeutics Jan 2023 - Present
    Enschede, Nl
  • 20Med Therapeutics
    Vp Research & Development
    20Med Therapeutics May 2019 - Mar 2023
    Enschede, Nl
  • Jaap Rip Consulting
    Formulation And Product Development
    Jaap Rip Consulting Jan 2019 - Mar 2023
    Consulting services for pharmaceutical industry with a focus on drug delivery and controlled release formulations
  • Nanomi
    Head Of Formulation Development
    Nanomi Apr 2016 - Dec 2018
    Oldenzaal, Nl
    Nanomi is a Dutch drug delivery company and a subsidiary of Lupin Limited. Leading the formulation team with the following tasks:1. formulation of sustained release complex injectable products2. in vitro and in vivo preclinical testing of developed formulations3. pharmacokinetics (PK) and In Vitro In Vivo Correlation (IVIVC) 4. prepare for scale-up and tech transfer5. responsible for IP and technology protection6. portfolio review7. team and people management
  • Eyesiu Medicines Bv
    Head Of Research And Development
    Eyesiu Medicines Bv Apr 2015 - Mar 2016
    Leiden, Nl
    Eyesiu Medicines BV creates crucially improved therapeutics based on advanced delivery technology for known anti-inflammatory eye care drugs with a favourable production process. As such, Eyesiu’s products are attractive for a wide range of market segments, both in human and veterinary medicine, and for multiple eye diseases. These developments will especially benefit patients, governments and regional companies in emerging economies, while the improved products also have the potential to address significant unmet medical needs in established markets.
  • Bbb Therapeutics
    Associate Director Research And Discovery
    Bbb Therapeutics Nov 2014 - Mar 2015
    Leiden, Nl
    Leading a team of 5 scientists and several external CROs for the preclinical development of BBB Therapeutics lead products and new liposomal formulations for the development pipeline. Involved as principal investigator in two European FP7 projects.
  • Bbb Therapeutics
    Senior Scientist Cns Targeting
    Bbb Therapeutics Jan 2009 - Oct 2014
    Leiden, Nl
    Involved in several internal and external research projects related to:• Development of liposomal drug delivery systems• Protein conjugation, analysis and quantification• In vitro product testing in (primary) mammalian cells• Preclinical in vivo product testing in animal disease models (oncology, CNS-related diseases, dyslipidemias)• Preclinical in vivo pharmacokinetic, biodistribution and toxicology studies
  • Department Of Pharmacology, Lacdr, Leiden University
    Postdoc
    Department Of Pharmacology, Lacdr, Leiden University Jan 2006 - Dec 2008
    Targeting of growth factors to treat stroke induced ischemia.
  • Department Of Vascular Medicine, Amc, Uva
    Phd Student
    Department Of Vascular Medicine, Amc, Uva Aug 2001 - Oct 2006
    Ph.D. thesis: Lipoprotein Lipase, Hypertriglyceridemia and Atherosclerosis. In collaboration with Amsterdam Molecular Therapeutics (AMT). The thesis includes the following topics: 1. LPL(S447X) metabolism in clinical and animal studies. 2. The development of AAV-LPL gene therapy by testing the efficacy in different dyslipidemic mouse model. 3. The detailed characterization of LPL deficient patients before enrolment in a clinical gene therapy trial.

Jaap Rip Skills

Lifesciences Cell Biology Biotechnology Biochemistry Drug Discovery Molecular Biology Drug Development In Vivo Cell Culture Neuroscience Pharmacodynamics Immunology In Vitro Animal Models Pharmacokinetics Drug Delivery Cell Immunohistochemistry Pcr Life Sciences Research And Development Formulation Pharmaceutical Industry Ivivc Pre Clinical Studies

Jaap Rip Education Details

  • Wageningen University & Research
    Wageningen University & Research
    Biology

Frequently Asked Questions about Jaap Rip

What company does Jaap Rip work for?

Jaap Rip works for 20med Therapeutics

What is Jaap Rip's role at the current company?

Jaap Rip's current role is CSO at 20Med Therapeutics.

What is Jaap Rip's email address?

Jaap Rip's email address is ri****@****bbb.com

What schools did Jaap Rip attend?

Jaap Rip attended Wageningen University & Research.

What skills is Jaap Rip known for?

Jaap Rip has skills like Lifesciences, Cell Biology, Biotechnology, Biochemistry, Drug Discovery, Molecular Biology, Drug Development, In Vivo, Cell Culture, Neuroscience, Pharmacodynamics, Immunology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.